Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 23994239)

1.

Significant modulation of macrophages associated cytokines TNF-α, VEGF and apoptotoic protein Bax, Bcl2 abrogates tumor cells.

Kumar P, Chatterjee S, Acharya S, Kumari A, Chaudhuri S, Singh MK, Ghosh SN, Chaudhuri S.

Cell Immunol. 2013 Jul-Aug;284(1-2):172-81. doi: 10.1016/j.cellimm.2013.07.020. Epub 2013 Aug 8.

PMID:
23994239
2.

T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells.

Bhattacharya D, Singh MK, Chaudhuri S, Acharya S, Basu AK, Chaudhuri S.

J Neurooncol. 2013 May;113(1):13-25. doi: 10.1007/s11060-013-1095-5. Epub 2013 Mar 8.

PMID:
23471571
3.
4.

CD2-SLFA3/T11TS interaction facilitates immune activation and glioma regression by apoptosis.

Sarkar S, Ghosh A, Mukherjee J, Chaudhuri S, Chaudhuri S.

Cancer Biol Ther. 2004 Nov;3(11):1121-8. Epub 2004 Nov 9.

5.

Immunomodulatory role of TIITS in respect to cytotoxic lymphocytes in four grades of human glioma.

Kumar P, Acharya S, Chatterjee S, Kumari A, Chaudhuri S, Singh MK, Ghosh SN, Chaudhuri S.

Cell Immunol. 2012 Mar-Apr;276(1-2):176-86. doi: 10.1016/j.cellimm.2012.05.006. Epub 2012 May 23.

PMID:
22704241
6.

AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alpha.

Mou K, Chen M, Mao Q, Wang P, Ni R, Xia X, Liu Y.

J Neurooncol. 2010 Dec;100(3):375-83. doi: 10.1007/s11060-010-0205-x. Epub 2010 May 14.

PMID:
20467785
7.

Documentation of immune profile of microglia through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3.

Begum Z, Ghosh A, Sarkar S, Mukherjee J, Mazumdar M, Sarkar P, Chaudhuri S.

Glycoconj J. 2004;20(9):515-23.

PMID:
15454689
8.

Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation.

Bhattacharjee M, Acharya S, Ghosh A, Sarkar P, Chatterjee S, Kumar P, Chaudhuri S.

Int Immunol. 2008 Dec;20(12):1489-505. doi: 10.1093/intimm/dxn109. Epub 2008 Oct 17.

9.

Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.

Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K, Kuwano M.

J Biol Chem. 1996 Nov 8;271(45):28220-8.

10.

Immunotherapeutic effects of T11TS/S-LFA3 against nitrosocompound mediated neural genotoxicity.

Mukherjee J, Sarkar S, Ghosh A, Duttagupta AK, Chaudhuri S, Chaudhuri S.

Toxicol Lett. 2004 May 2;150(3):239-57.

PMID:
15110076
11.
12.

Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.

Akbasak A, Oldfield EH, Saris SC.

J Neurosurg. 1991 Dec;75(6):922-9.

PMID:
1941122
13.

Tumor necrosis factor reduces brain tumor growth by enhancing macrophage recruitment and microcyst formation.

Villeneuve J, Tremblay P, Vallières L.

Cancer Res. 2005 May 1;65(9):3928-36.

14.

Inhibition of Nodal suppresses angiogenesis and growth of human gliomas.

Hueng DY, Lin GJ, Huang SH, Liu LW, Ju DT, Chen YW, Sytwu HK, Chang C, Huang SM, Yeh YS, Lee HM, Ma HI.

J Neurooncol. 2011 Aug;104(1):21-31. doi: 10.1007/s11060-010-0467-3. Epub 2010 Nov 30.

PMID:
21116837
15.

Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.

Kaliberov S, Stackhouse MA, Kaliberova L, Zhou T, Buchsbaum DJ.

Gene Ther. 2004 Apr;11(8):658-67.

PMID:
14973547
16.

T11 target structure induced modulations of the pro-inflammatory and anti-infammatorycytokine expressions in experimental animals for glioma abrogation.

Singh MK, Chaudhuri S, Bhattacharya D, Kumar P, Datta A, Chaudhuri S.

Int Immunopharmacol. 2015 Feb;24(2):198-207. doi: 10.1016/j.intimp.2014.12.010. Epub 2014 Dec 17.

PMID:
25528475
17.

Evaluation of TNF-alpha/Bax gene therapy and radiation against C6 glioma xenografts.

Gridley DS, Timiryasova TM, Miller GM, Andres ML, Dutta-Roy R, Bayeta EJ, Fodor I.

Technol Cancer Res Treat. 2003 Feb;2(1):41-50.

PMID:
12625753
18.

Dynamics of central and peripheral immunomodulation in a murine glioma model.

Kennedy BC, Maier LM, D'Amico R, Mandigo CE, Fontana EJ, Waziri A, Assanah MC, Canoll P, Anderson RC, Anderson DE, Bruce JN.

BMC Immunol. 2009 Feb 18;10:11. doi: 10.1186/1471-2172-10-11.

19.
20.

Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.

Xu Y, Zhong Z, Yuan J, Zhang Z, Wei Q, Song W, Chen H.

Cancer Epidemiol. 2013 Oct;37(5):697-702. doi: 10.1016/j.canep.2013.06.006. Epub 2013 Jul 17.

PMID:
23870768
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk